Seizert Capital Partners, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Seizert Capital Partners, LLC

$2.16 Billion
Q3 2024

A detailed history of Seizert Capital Partners, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Seizert Capital Partners, LLC holds 45,775 shares of REGN stock, worth $34 Million. This represents 2.23% of its overall portfolio holdings.

Number of Shares

45,775

Previous 51,960 11.9%

Holding current value

$34 Million

Previous $54.6 Million 11.89%

% of portfolio

2.23%

Previous 2.78%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$1024.09 - $1201.76 $6.33 Million - $7.43 Million	-6,185 Reduced 11.9%	45,775 $48.1 Million
Q2 2024 Aug 07, 2024	SELL	$883.2 - $1071.19 $3.85 Million - $4.66 Million	-4,354 Reduced 7.73%	51,960 $54.6 Million
Q1 2024 May 01, 2024	BUY	$902.69 - $993.35 $490,160 - $539,389	543 Added 0.97%	56,314 $54.2 Million
Q4 2023 Feb 07, 2024	SELL	$775.18 - $881.7 $2.34 Million - $2.67 Million	-3,024 Reduced 5.14%	55,771 $49 Million
Q3 2023 Nov 06, 2023	BUY	$692.45 - $844.37 $916,111 - $1.12 Million	1,323 Added 2.3%	58,795 $48.4 Million
Q2 2023 Jul 27, 2023	SELL	$700.03 - $830.35 $676,228 - $802,118	-966 Reduced 1.65%	57,472 $41.3 Million
Q1 2023 May 09, 2023	SELL	$680.49 - $826.97 $2.92 Million - $3.55 Million	-4,288 Reduced 6.84%	58,438 $48 Million
Q4 2022 Jan 30, 2023	SELL	$705.89 - $766.39 $6.18 Million - $6.71 Million	-8,752 Reduced 12.24%	62,726 $45.3 Million
Q3 2022 Nov 02, 2022	SELL	$573.97 - $724.32 $7.93 Million - $10 Million	-13,823 Reduced 16.2%	71,478 $49.2 Million
Q2 2022 Aug 04, 2022	BUY	$548.35 - $738.84 $2.03 Million - $2.73 Million	3,696 Added 4.53%	85,301 $50.4 Million
Q1 2022 May 03, 2022	SELL	$595.12 - $698.43 $3.43 Million - $4.02 Million	-5,757 Reduced 6.59%	81,605 $57 Million
Q4 2021 Feb 08, 2022	SELL	$543.48 - $670.97 $944,024 - $1.17 Million	-1,737 Reduced 1.95%	87,362 $55.2 Million
Q3 2021 Nov 03, 2021	BUY	$574.03 - $680.96 $1.17 Million - $1.39 Million	2,037 Added 2.34%	89,099 $53.9 Million
Q2 2021 Aug 05, 2021	BUY	$472.8 - $558.54 $1.17 Million - $1.39 Million	2,485 Added 2.94%	87,062 $48.6 Million
Q1 2021 May 05, 2021	BUY	$446.73 - $548.2 $16.1 Million - $19.7 Million	35,991 Added 74.08%	84,577 $40 Million
Q4 2020 Feb 08, 2021	BUY	$478.3 - $607.98 $6.15 Million - $7.81 Million	12,852 Added 35.97%	48,586 $23.5 Million
Q3 2020 Nov 03, 2020	SELL	$544.75 - $658.21 $387,317 - $467,987	-711 Reduced 1.95%	35,734 $20 Million
Q2 2020 Aug 06, 2020	SELL	$493.32 - $643.92 $1.99 Million - $2.6 Million	-4,033 Reduced 9.96%	36,445 $22.7 Million
Q1 2020 May 05, 2020	SELL	$336.18 - $494.43 $8.87 Million - $13 Million	-26,381 Reduced 39.46%	40,478 $19.8 Million
Q4 2019 Feb 10, 2020	SELL	$274.13 - $376.51 $2.53 Million - $3.47 Million	-9,228 Reduced 12.13%	66,859 $25.1 Million
Q3 2019 Nov 07, 2019	BUY	$273.46 - $318.39 $20.8 Million - $24.2 Million	76,087 New	76,087 $21.1 Million

Others Institutions Holding REGN

# of Institutions

1,531

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Seizert Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Seizert Capital Partners, LLC with notifications on news.

Account

Seizert Capital Partners, LLC Regeneron Pharmaceuticals, Inc. Transaction History